blog

We blog about genomics. We also make a platform for open-source analysis of next generation data in the cloud. Hello.

Festival of Genomics: Reflecting on graph genomes

Nick

Graph Genome, Science

Yesterday at Festival of Genomics, London, Seven Bridges CEO Deniz Kural joined a panel discussing implementations of graph genomes, alongside Erik Garrison from the Wellcome Trust Sanger Institute and Andy Yates from EMBL-EBI. Great panel talking about #graph #genomes at #GenomicsFest @erikgarrison @denizkural Andrew Yates @FLGenomics pic.twitter.com/4Cxy2CslvT — Adrian Alexa

continue reading

Bioinformatics applications in cancer immunotherapy

Jessica Lau

Science

An emerging characteristic, or hallmark, of cancer cells is their ability to evade destruction by the immune system. While immune surveillance plays a role in controlling tumorigenesis and tumor progression, cancer cells can in turn disable the immune system by secreting immunosuppressive factors or recruiting immunosuppressive cells. Because of this

continue reading

The race for a revolutionary new cancer diagnosis tool: The Blood Profiling Atlas in Cancer

Patrick

Blood Profiling, Cancer Moonshot, Science, Useful Data

A revolutionary approach to cancer diagnosis Liquid biopsy, a new technique for tracking down fragments of tumor DNA in the blood, has the potential to revolutionize how cancer is diagnosed and treated. At next week’s Precision Medicine World Congress, Seven Bridges’ Bruce Press will lead the “Update on the Cancer

continue reading

Making efficient use of your compute resources

Andrea Szollossi

Platform

The non-trivial matter of optimising compute resources available for your analysis is brought into the spotlight. We discuss when you might benefit from optimising the compute resources available for your analysis as well as how you can achieve this on the Seven Bridges Platform. Examples of effective management of large

continue reading

Price reductions on AWS mean reduced billing for users

Nick

Product News

As a provider of cloud-based biomedical data analysis services, we are aware that our users compare the long-term storage costs of cloud computing relative to local storage. Amazon Web Services (AWS) recently announced price reductions for both S3 and Glacier cloud storage. Seven Bridges passes through cloud computing and storage

continue reading

Seven Bridges Platform Integration with SolveBio

Nick

Product News

Yesterday we announced the integration of the Seven Bridges Platform for cloud-based biomedical data analysis with SolveBio. This integration enables biotech and pharmaceutical researchers to seamlessly transition from the analysis of large NGS datasets to clinical analysis and interpretation, speeding the progress of their precision medicine initiatives. The integration is available

continue reading

Seven Bridges and the EU-U.S. Privacy Shield

Nick

Compliance / Security

Seven Bridges is an early adopter and strong supporter of the EU-US Privacy Shield, a framework in which US companies pledge to adhere to EU standards of data protection. Privacy Shield, designed by the US Department of Commerce and the European Commission, allows companies to comply with EU data protection requirements

continue reading

We are always engaged in research and development, working to build the future of genomics, science, and health. Let’s work together. We’d love to hear about your projects and challenges, so drop us a line.

get in touch